Osiris Therapeutics to Present at the JMP Securities Healthcare Focus Conference

Osiris Completes Enrollment of Stem Cell Trial to Treat Pulmonary Disease

Osiris Therapeutics to Present at the 2008 UBS Global Life Sciences Conference

Osiris Therapeutics to Present at Thomas Weisel Partners Healthcare Conference

Osiris Therapeutics Reports Second Quarter 2008 Financial Results

Osiris Announces Second Quarter 2008 Financial Results Conference Call

Osiris Therapeutics Appoints Chief Financial Officer

NuVasive Completes Acquisition of Osteocel Biologics Business

Osiris Therapeutics Closes Osteocel Transaction Worth up to $137 Million

Osiris Therapeutics Announces $2 Million Milestone Payment for Clinical Progress of a Stem Cell Therapy for Type 1 Diabetes

Osiris Therapeutics to Present at the Jefferies Second Annual Healthcare Conference

Osiris Therapeutics to Present at the Piper Jaffray Europe Conference

Osiris Therapeutics to Present at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference

Osiris Therapeutics to Present at the Canaccord Adams Diabetes and Obesity Conference

Osiris Therapeutics Initiates Phase II Clinical Trial Evaluating Prochymal(TM) for Chronic Obstructive Pulmonary Disease

Osiris Therapeutics Reports First Quarter 2008 Financial Results

Osiris and NuVasive Enter into Definitive Agreement for Osteocel(R)

NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics

Osiris Receives Approval for Use of Prochymal(TM) Under FDA Expanded Access Treatment Program

Osiris Announces First Quarter 2008 Financial Results Conference Call